We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 2,202

Oncology drives major pharma deals while immuno-oncology patent activity soars
  • IAM
  • Global
  • May 23 2018

Cancer immunotherapy is an exciting, relatively new therapy that treats cancer by unleashing the power of the immune system. It has been hailed as one


AI, blockchain and IoT patents all on the shopping list for latest IP3 buying programme
  • IAM
  • Global
  • May 22 2018

Details of the latest iteration of IP3, the patent buying programme hosted by AST designed to give IP owners a quick and efficient way of selling


International Trade Compliance Update - May 2018
  • Baker McKenzie
  • Global
  • May 21 2018

The first review of the trade policies and practices of Montenegro took place on 11 and 13 April 2018. The basis for the review was a report by the


Patent enforcement through the courts in the USA
  • Paul Weiss
  • USA, Global
  • May 10 2018

A structured guide to enforcing patents through the courts in the USA


An overview of patentability in the USA
  • Paul Weiss
  • USA, Global
  • May 10 2018

An overview of patentability in the USA


Patents in the USA
  • Paul Weiss
  • USA, Global
  • May 10 2018

A structured guide to patents law and practice in the USA


Anti-counterfeiting: Is it time to review your approach?
  • Novagraaf
  • Global
  • May 8 2018

Budgeting for anti-counterfeiting activity can be a challenge for IP heads because it can be hard to find up-to-date and consistent data to estimate


CRISPR dust-up; compulsory licensing in China; Novartis CEO wants US reform, and more April's Life Sciences IP Round-up
  • IAM
  • USA, China, Global, India
  • May 7 2018

In this month’s round-up of life sciences-related patent news, we report on the year’s first pharma mega-merger, the latest developments in a


Israel's innovation story is extraordinary, but just assuming it will continue would be a big mistake
  • IAM
  • Global, Israel
  • May 6 2018

Some statistics for you: Israel has a population of 8.5 million Israel spends 4.8 of its GDP on civilian R&D - the highest of any OECD country Israel


Highlights of Design Day 2018
  • Banner & Witcoff Ltd
  • USA, Global, Japan
  • May 4 2018

After Andrei Iancu, the director of the USPTO, kicked off the event and expressed the importance of the design patent system, Karen Young, the group